<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yamazaki S</submitter><funding>Core Research for Evolutional Science and Technology</funding><funding>Takeda Science Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Uehara Memorial Foundation</funding><funding>Japan Science and Technology Agency</funding><pagination>414-425</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937152</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(3)</volume><pubmed_abstract>Myeloid cells, which originate from hematopoietic stem/progenitor cells (HSPCs), play a crucial role in mitigating infections. This study aimed to explore the impact of mesenchymal stem/stromal cells (MSCs) on the differentiation of HSPCs and progenitors through the C-C motif chemokine CCL2/CCR2 signaling pathway. Murine MSCs, identified as PDGFRα&lt;sup>+&lt;/sup>Sca-1&lt;sup>+&lt;/sup> cells (PαS cells), were found to secrete CCL2, particularly in response to lipopolysaccharide stimulation. MSC-secreted CCL2 promoted the differentiation of granulocyte/macrophage progenitors into the myeloid lineage. MSC-derived CCL2 plays an important role in the early phase of myeloid cell differentiation in vivo. Single-cell RNA sequencing analysis confirmed that CCL2-mediated cell fate determination was also observed in human bone marrow cells. These findings provide valuable insights for investigating the in vivo effects of MSC transplantation.</pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.</pubmed_title><pmcid>PMC10937152</pmcid><funding_grant_id>JP20bm0404031h0103</funding_grant_id><funding_grant_id>JP18KK0449</funding_grant_id><funding_grant_id>JP21H03328</funding_grant_id><funding_grant_id>JP18bm0404022h0001</funding_grant_id><funding_grant_id>23bm1223011h0001</funding_grant_id><funding_grant_id>JPMJCR2124</funding_grant_id><funding_grant_id>JP19KK0216</funding_grant_id><funding_grant_id>JP19K10024</funding_grant_id><pubmed_authors>Azuma Y</pubmed_authors><pubmed_authors>Mabuchi Y</pubmed_authors><pubmed_authors>Morishita S</pubmed_authors><pubmed_authors>Kikuchi R</pubmed_authors><pubmed_authors>Suto EG</pubmed_authors><pubmed_authors>Kimura T</pubmed_authors><pubmed_authors>Kondo A</pubmed_authors><pubmed_authors>Hisamatsu D</pubmed_authors><pubmed_authors>Akazawa C</pubmed_authors><pubmed_authors>Komatsu N</pubmed_authors><pubmed_authors>Nishikii H</pubmed_authors><pubmed_authors>Naraoka Y</pubmed_authors><pubmed_authors>Araki M</pubmed_authors><pubmed_authors>Yamazaki S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.</name><description>Myeloid cells, which originate from hematopoietic stem/progenitor cells (HSPCs), play a crucial role in mitigating infections. This study aimed to explore the impact of mesenchymal stem/stromal cells (MSCs) on the differentiation of HSPCs and progenitors through the C-C motif chemokine CCL2/CCR2 signaling pathway. Murine MSCs, identified as PDGFRα&lt;sup>+&lt;/sup>Sca-1&lt;sup>+&lt;/sup> cells (PαS cells), were found to secrete CCL2, particularly in response to lipopolysaccharide stimulation. MSC-secreted CCL2 promoted the differentiation of granulocyte/macrophage progenitors into the myeloid lineage. MSC-derived CCL2 plays an important role in the early phase of myeloid cell differentiation in vivo. Single-cell RNA sequencing analysis confirmed that CCL2-mediated cell fate determination was also observed in human bone marrow cells. These findings provide valuable insights for investigating the in vivo effects of MSC transplantation.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-24T03:08:30.56Z</modification><creation>2026-06-24T03:06:11.122Z</creation></dates><accession>S-EPMC10937152</accession><cross_references><pubmed>38428413</pubmed><doi>10.1016/j.stemcr.2024.02.002</doi></cross_references></HashMap>